Insiders / Boyce Sarah

Boyce Sarah

CIK 1629383personinsider
Companies
2
First seen
Jan 9, 2026
Last activity
Mar 2, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Avidity Biosciences, Inc. · RNACEO0283,39411
Atrium Therapeutics, Inc. · RNADirector20,0001

All securities held

1 position · latest reported per filing
CompanySecuritySharesAs of
Atrium Therapeutics, Inc.Stock Option (Right to Buy)Derivative20,000Feb 27, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jan 7, 2026SellRNA
Avidity Biosciences, Inc.
Common Stock
$619.4K-9K
-2.94%
283,394
0.18% of shares
medium
Jan 21, 2026SellRNA
Avidity Biosciences, Inc.
Common Stock
$579.1K-8K
-2.89%
269,007
0.17% of shares
medium
Jan 21, 2026SellRNA
Avidity Biosciences, Inc.
Common Stock
$463.2K-6K
-2.26%
277,000
0.18% of shares
medium
Feb 27, 2026GrantRNA
Atrium Therapeutics, Inc.
Stock Option (Right to Buy)
+20K
20,000
0.12% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-165K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-300K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-200K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-400K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-425K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-300K
-100.00%
0
0.00% of shares
low